{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:35:01Z","timestamp":1793349301260,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571638"],"award-info":[{"award-number":["81571638"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Phospholamban (PLN) is an important regulator for sarcoendoplasmic reticulum (SR) calcium transport ATPase (SERCA), which uptakes Ca<jats:sup>2+<\/jats:sup> to SR during the diastolic phase of cardiomyocytes to maintain intracellular calcium homeostasis. Mutations on PLN result in intracellular calcium disorder, myocardial contraction defect, and eventually heart failure and\/or malignant ventricular arrhythmia. Since 2003, several kinds of PLN mutations have been identified in familial dilated cardiomyopathy (DCM) patients, illustrating a few clinical characteristics that differs from classical DCM patients. Herein, we report a large PLN-R14del family with typical clinical characteristics reported including relatively late-onset clinical symptoms, low-voltage in ECG, as well as frequent ventricular arrythmias. Moreover, members underwent cardiac magnetic resonance (CMR) examination showed a strikingly similar pattern of late gadolinium enhancement (LGE)\u2014Sub-epicardial involvement in the left ventricular (LV) lateral wall with or without linear mid-wall enhancement in the interventricular septum. The former one can also present in younger PLN-R14del carriers despite completely normal LV structure and function. Meanwhile, T1 mapping also found significantly increased extracellular volume (ECV) in PLN-R14del carriers. These findings highlight the special role of CMR to phenotyping PLN-induced cardiomyopathy patients and distinguish them from other types of cardiomyopathy.<\/jats:p>","DOI":"10.1038\/s41598-020-73359-8","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T10:05:05Z","timestamp":1601892305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The phenotypic characteristic observed by cardiac magnetic resonance in a PLN-R14del family"],"prefix":"10.1038","volume":"10","author":[{"given":"Xincheng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,5]]},"reference":[{"issue":"10092","key":"73359_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub, R. G. et al. Dilated cardiomyopathy. Lancet 390(10092), 400\u2013414 (2017).","journal-title":"Lancet"},{"issue":"7","key":"73359_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm1151","volume":"4","author":"DH MacLennan","year":"2003","unstructured":"MacLennan, D. H. & Kranias, E. G. Phospholamban: A crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4(7), 566\u2013577 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"73359_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.bbamem.2018.02.030","volume":"1860","author":"SED Nelson","year":"2018","unstructured":"Nelson, S. E. D. et al. Effects of the Arg9Cys and Arg25Cys mutations on phospholamban\u2019s conformational equilibrium in membrane bilayers. Biochim. Biophys. Acta Biomembr. 1860(6), 1335\u20131341 (2018).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"1","key":"73359_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/bcb-2014-0080","volume":"93","author":"HS Young","year":"2015","unstructured":"Young, H. S. et al. Deception in simplicity: Hereditary phospholamban mutations in dilated cardiomyopathy. Biochem. Cell Biol. 93(1), 1\u20137 (2015).","journal-title":"Biochem. Cell Biol."},{"issue":"5","key":"73359_CR5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1073\/pnas.0510519103","volume":"103","author":"K Haghighi","year":"2006","unstructured":"Haghighi, K. et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc. Natl. Acad. Sci. USA 103(5), 1388\u20131393 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"32","key":"73359_CR6","doi-asserted-by":"publisher","first-page":"26596","DOI":"10.1074\/jbc.M112.382713","volume":"287","author":"DK Ceholski","year":"2012","unstructured":"Ceholski, D. K. et al. Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A. J. Biol. Chem. 287(32), 26596\u201326605 (2012).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"73359_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.hrthm.2009.01.016","volume":"6","author":"MG Posch","year":"2009","unstructured":"Posch, M. G. et al. Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. Heart Rhythm. 6(4), 480\u2013486 (2009).","journal-title":"Heart Rhythm."},{"issue":"7","key":"73359_CR8","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.hrthm.2017.03.034","volume":"14","author":"S Sepehrkhouy","year":"2017","unstructured":"Sepehrkhouy, S. et al. Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies. Heart Rhythm. 14(7), 1024\u20131032 (2017).","journal-title":"Heart Rhythm."},{"key":"73359_CR9","unstructured":"Wallis, Y. et al. Practice Guidelines for the Evaluation of Pathogenicity and the Reporting of Sequence Variants in Clinical Molecular Genetics. Association for Clinical Genetic Science (2013)."},{"issue":"11","key":"73359_CR10","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1074\/jbc.M114.630319","volume":"290","author":"N Abrol","year":"2015","unstructured":"Abrol, N. et al. Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban. J. Biol. Chem. 290(11), 7130\u20137140 (2015).","journal-title":"J. Biol. Chem."},{"issue":"20","key":"73359_CR11","doi-asserted-by":"publisher","first-page":"16521","DOI":"10.1074\/jbc.M112.360859","volume":"287","author":"DK Ceholski","year":"2012","unstructured":"Ceholski, D. K. et al. Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy. J. Biol. Chem. 287(20), 16521\u201316529 (2012).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"73359_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/CIRCULATIONAHA.108.783506","volume":"119","author":"JP Schmitt","year":"2009","unstructured":"Schmitt, J. P. et al. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition. Circulation 119(3), 436\u2013444 (2009).","journal-title":"Circulation"},{"issue":"11","key":"73359_CR13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","volume":"14","author":"PA van der Zwaag","year":"2012","unstructured":"van der Zwaag, P. A. et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: Evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur. J. Heart Fail. 14(11), 1199\u20131207 (2012).","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"73359_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","volume":"106","author":"E Kayvanpour","year":"2017","unstructured":"Kayvanpour, E. et al. Genotype-phenotype associations in dilated cardiomyopathy: Meta-analysis on more than 8000 individuals. Clin. Res. Cardiol. 106(2), 127\u2013139 (2017).","journal-title":"Clin. Res. Cardiol."},{"issue":"5","key":"73359_CR15","first-page":"683","volume":"36","author":"XY Chen","year":"2005","unstructured":"Chen, X. Y. et al. Association between phospholamban gene mutation and dilated cardiomyopathy in the Chengdu area. Sichuan Da Xue Xue Bao Yi Xue Ban 36(5), 683\u2013685 (2005).","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"5","key":"73359_CR16","first-page":"599","volume":"26","author":"CX Zhao","year":"2004","unstructured":"Zhao, C. X. et al. Association between mutation of phospholamban gene and dilated cardiomyopathy. Yi Chuan 26(5), 599\u2013602 (2004).","journal-title":"Yi Chuan"},{"key":"73359_CR17","doi-asserted-by":"crossref","unstructured":"Nakamori, S., Dohi, K., Ishida, M., et al. Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc. Imaging, 2017:S1936878X1730400X.","DOI":"10.1016\/j.jcmg.2017.04.006"},{"issue":"9","key":"73359_CR18","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1007\/s00330-017-4817-9","volume":"27","author":"JC Youn","year":"2017","unstructured":"Youn, J. C. et al. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: A prospective cohort study. Eur. Radiol. 27(9), 3924\u20133933 (2017).","journal-title":"Eur. Radiol."},{"issue":"4","key":"73359_CR19","doi-asserted-by":"publisher","first-page":"e94820","DOI":"10.1371\/journal.pone.0094820","volume":"9","author":"JM Gho","year":"2014","unstructured":"Gho, J. M. et al. High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy. PLoS ONE 9(4), e94820 (2014).","journal-title":"PLoS ONE"},{"issue":"2","key":"73359_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12471-018-1211-4","volume":"27","author":"IE Hof","year":"2019","unstructured":"Hof, I. E. et al. Prevalence and cardiac phenotype of patients with a phospholamban mutation. Neth. Heart J. 27(2), 64\u201369 (2019).","journal-title":"Neth. Heart J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73359-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:07:19Z","timestamp":1670357239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73359-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,5]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73359"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73359-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,5]]},"assertion":[{"value":"3 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16478"}}